Related by context. All words. (Click for frequent words.) 66 glucocerebrosidase GCD 65 taliglucerase alfa 65 commercialize XP# 63 Taliglucerase alfa 63 commercialize Aganocides 63 Uplyso 63 commercialize telaprevir 62 HuMax TAC 62 Aviptadil 62 glucocerebrosidase 61 targeted anticancer biopharmaceuticals 61 NASDAQ CGEN announced 61 commercialize Dimebon 61 acne impetigo 61 Cx# [002] 60 JOULFERON 60 Kuvan R 60 DP VPA 60 Glassia 60 Fresenius Biotech 60 Astellas Deutschland GmbH 60 commercialize XL# 60 GA GCB 60 Pancreate 59 successfully commercialize Iluvien 59 Gamida Cell Ltd. 59 Plicera 59 NurOwn 59 Inc. www.micromet inc.com 59 Campath ® 59 commercialize SGN 59 Allos retains exclusive 59 Iluvien ® 59 commercialize deforolimus 59 molecular chaperone regulation 59 Megapharm Ltd. 59 lixivaptan 59 Gentamicin Surgical Implant 59 Zavesca r 59 Crucell PER.C6 59 Galderma SA 59 R sorafenib tablets 59 Crucell PER.C6 ® 59 Personalized Immunotherapy 59 LymphoStat B belimumab 58 Cell Cure Neurosciences 58 methylnaltrexone bromide 58 Albugon 58 kidney urologic 58 ddRNAi 58 prGCD 58 bendamustine HCl 58 novel therapeutic antibodies 58 HuCNS SC ® 58 TRACON Pharmaceuticals 58 GTC recombinant human 58 Gaucher Disease 58 Handok 58 Onalta 58 Pluristem Therapeutics 58 GTC NASDAQ GTCB 58 developing Zerenex ferric 58 Modrenal R 58 commercialize Isotechnika lead 58 Behcet uveitis 58 LymphoStat B TM 58 TRIOLEX HE# APOPTONE HE# 58 commercialize AzaSite 58 Receives Fast Track 58 adult multipotent stem 58 targeted radiotherapeutic 58 beta islets 58 Peginterferon alfa 2b 58 gabapentin enacarbil 57 ATG Fresenius S 57 sodium glucose transporter 57 Initiates Phase II 57 ZALBIN 57 TaiGen 57 GammaCan 57 Somatuline Depot 57 Nycomed GmbH 57 Oral Calcitonin 57 commercialize OncoGenex lead 57 Aurexis 57 BioSante Pharmaceuticals Announces 57 EVIZON TM 57 therapeutic monoclonal antibodies 57 commercialize becocalcidiol patented 57 small molecule thrombopoietin 57 pharmacological chaperone 57 Granted Orphan Drug 57 Dynepo TM 57 Loramyc ™ 57 Cetrorelix 57 Quark Biotech 57 Vertex retains 57 ZBx 57 polysaccharide polymer 57 RTP #i 57 acetonide FA 57 GRNOPC1 contains 57 Gaucher disease 57 HepaGam B 57 Taiho Pharmaceutical 57 TKM PLK1 57 commercialize elagolix 57 Nasdaq CLDX 57 Civacir 57 Initiates Enrollment 57 commercialize CK # 57 ATL# [002] 57 commercialize JX 57 hyperimmune products 57 DepoBupivacaine TM 57 Meda STO MEDAA 57 Rescula 57 delivers fluocinolone acetonide FA 57 BLRX 57 CORLUX CORT # 57 Onalta TM 57 Quark Biotech Inc. 57 CIMAB SA 57 aerosolized AAT 57 Loramyc TM 57 Maxy G# 57 Vitrasert R 57 Kineret 56 MorphoSys proprietary 56 Alligator Bioscience AB 56 PrevOnco ™ 56 Crofelemer budesonide foam 56 HuMax CD4 56 terlipressin 56 FDA Orphan Drug 56 NYSE Amex PLX 56 PDE# inhibitors 56 Nanobody R 56 ospemifene 56 Protalix BioTherapeutics 56 Cerashield ™ 56 Immuron 56 Completes Patient Enrollment 56 Enters Into Collaboration 56 ImmunoGen TAP technology 56 memantine HCl 56 commercialize apixaban 56 volociximab 56 novel antiviral therapeutics 56 InterfeRx 56 Begins Dosing 56 nasal calcitonin product 56 Initiates Clinical 56 CIMYM 56 YONDELIS R 56 Minapharm 56 drug ISA# 56 NurOwn ™ 56 Receives Orphan Drug Designation 56 valtorcitabine 56 Potelligent Technology 56 StromaCel Inc. 56 BioView 56 UltiMAb ® 56 RhuDex R 56 exclusive sublicense 56 Increlex TM 56 commercialize microRNA therapeutics 56 Zenapax 56 Canvaxin TM 56 Misonix Announces 56 Nabi HB Intravenous 56 Fabry Disease 56 relapsed leukemia 56 liposomal delivery 56 primordial germ cells 56 CysDisplay R 56 IMiDs 56 Therapeutic Competitors Companies 56 Gamunex C 56 BioLineRx Ltd. 56 Liprotamase 56 commercialize Hematide 56 Martin Nicklasson CEO 56 Namenda Memantine HCl 56 Initiates Dosing 56 Dynepo 56 ImmunoGen maytansinoid TAP 56 Receives Milestone Payment 55 CollaRx GENTAMICIN SURGICAL IMPLANT 55 HGS ETR1 mapatumumab 55 sub licensable 55 EGRIFTA TM 55 vivo validation 55 manufactures minimally invasive 55 TRACON Pharmaceuticals Inc. 55 Combidex 55 Biotica Technology 55 Argatroban 55 REPLAGAL 55 commercialize teduglutide outside 55 developing TB4 55 Nippon Kayaku 55 synthetic peptide containing 55 Receive Milestone Payment 55 tivozanib AV 55 Nippon Shinyaku 55 Initiates Clinical Trial 55 Uvidem 55 pancreatic alpha 55 Initiate Clinical Trial 55 Prestara 55 UMN Pharma 55 LUCASSIN 55 FOLOTYN ® 55 5 lipoxygenase inhibitor 55 fusion enhancers 55 thymidylate synthase TS 55 Thrombin topical Recombinant 55 Fast Track Status 55 Roche SWX ROG 55 Budesonide foam crofelemer 55 Fortical R 55 Submits IND 55 BioSante 2A/Furin technology 55 Compugen Ltd. 55 Uracyst R 55 XIAFLEX ™ 55 InvaGen 55 RhuDex ® 55 Files IND 55 LHRH antagonist 55 Announce License Agreement 55 NeoVisc ® 55 Fortical ® 55 YONDELIS 55 non porcine pancreatic 55 Evoltra ® 55 non nucleoside inhibitor 55 recombinant biopharmaceutical 55 candidate custirsen 55 Savene ® 55 BENLYSTA ® 55 Zenyaku Kogyo 55 cosmetic cosmeceutical products 55 pSivida owns 55 E1 INT TM 55 Nasdaq CGEN 55 Zorbtive TM 55 Epitomics 55 telomerase therapeutic 55 Clofarabine 55 intravenous AAT 55 Orient Europharma 55 Submits Response 55 Galenea 55 IV Busulfex 55 ZFP Therapeutics 55 faropenem 55 MOVIPREP R 55 DPX Survivac 55 trademarks Vitrasert R 55 anti CD3 monoclonal 55 beta 1a 55 2A receptor agonist 55 UPLYSO 55 Protalix Biotherapeutics 55 Teijin Pharma 55 Oncobionic 55 Syncria 55 IMiDs ® 55 sapropterin dihydrochloride 55 PharmaSwiss SA 55 BioLineRx Ltd. TASE 55 Prolor 55 Provectus Pharmaceuticals specializes 55 Kepivance 55 Receives Orphan Drug 55 PER.C6 r 55 Osiris retains 55 rThrombin 55 EP #R 55 adipose derived stem cell 55 GVAX ® 55 mitogen activated ERK kinase 55 OMAPRO ™ 55 Nasdaq CRXL 55 Yissum Research 55 RELISTOR ® 55 Protalix 55 epoprostenol sodium 55 MolecularBreeding 55 Gleevec resistant 54 Bioral Amphotericin B 54 Systemic Delivery 54 VitiGam 54 oral dual endothelin 54 Morquio 54 TYZEKA 54 Campto 54 Gamida Cell 54 JAK inhibitors 54 Hexvix ® 54 Bendamustine 54 Æterna Zentaris 54 ViroChem 54 MyVax ® 54 candidate deforolimus 54 TBC# 54 Uracyst ® 54 liver resection surgeries 54 acyclovir Lauriad R 54 EMD Biosciences Inc. 54 PHX# 54 Factor XIII 54 Synerx 54 commercialize pimavanserin 54 Teikoku Pharma USA 54 R Saizen R 54 Annamycin 54 Icatibant 54 Norgine BV 54 RenaZorb TM 54 hyaluronidase enzyme 54 5 HT4 54 Syntonix 54 Multiferon 54 cSSTI 54 VIVITROL ® 54 OHR/AVR# 54 Cellgate Inc. 54 Scancell 54 Replagal TM 54 Soliris eculizumab 54 rasagiline tablets 54 soluble tumor necrosis 54 GenWay Biotech 54 Difimicin 54 Tyzeka Sebivo 54 selective immunoproteasome inhibitor 54 Helsinn Healthcare SA 54 SciGen 54 Diamyd ® 54 Veronate 54 Nasdaq ALNY 54 inhaled AAT 54 retinoic acid receptor 54 TFChem 54 SNY SAN.FR 54 Agensys subsidiary 54 R alglucosidase alfa 54 cells hESCs 54 License Option Agreement 54 vitreoretinal disorders 54 Protalix BioTherapeutics Inc 54 Cenomed 54 Recombinant Human 54 molecular imaging radiopharmaceutical 54 Canvaxin 54 neurogenic bladder 54 Vaccinex 54 Taiho Pharmaceutical Co. 54 Cerashield 54 phenylketonuria 54 chronic granulomatous disease 54 Azacitidine 54 CDP# 54 CIMZIA r 54 Fodosine 54 unoprostone isopropyl 54 adrenergic regulation 54 Neulasta R 54 Umbilical cord stem cells 54 R bendamustine hydrochloride 54 Urocidin TM 54 Rhucin ® recombinant 54 Kaketsuken 54 Syndrome LEMS 54 Neo Bladder Augment 54 Handok Pharmaceuticals 54 compound KOS 54 Alnylam RNAi 54 Nasdaq MITI biopharmaceutical 54 Prometheus Laboratories 54 Genzyme Cerezyme 54 co licensor KDL 54 Silodosin 54 Oncophage vitespen 54 anticoagulant reversing agent 54 GED aPC 54 Spiegelmer ® 54 AMEX PLX 54 Procognia 54 eprodisate KIACTA TM 54 Achieves Primary Endpoint 54 MERREM 54 Bioaccelerate compounds under 54 MYDICAR ® 54 proprietary radiolabeled monoclonal 54 MTP inhibitor 54 highly selective adenosine 54 calcitonin salmon nasal spray 54 biotherapeutic drugs 54 injectable collagenase 54 Fludara ® 54 Loramyc 54 Retacrit 54 Lixivaptan 54 small molecule Hedgehog 54 HepeX B 54 PRN FDA Approves 54 Kineret ® 54 PROLACRIA ™ 54 ATryn ® 54 TNF Tumor Necrosis Factor 54 Dacogen decitabine 54 staphylococcal vaccines 54 Ganciclovir 54 Granulocyte Colony Stimulating Factor 54 GlaxoSmithKline Biologicals SA 54 Reports Preclinical Data 54 HCV protease inhibitors 54 Archemix Corp. 54 humanized therapeutic 54 ACTCellerate 54 peptibody 54 Oncaspar 54 novel antibody therapeutics 54 Drug Candidate 54 rxRNA 54 commercialize SB# 54 Tectin TM 54 Rexahn licensees 54 PDE4 inhibitor 54 Fovea Pharmaceuticals 54 DARA logo 54 Piperacillin 54 targeted immunotherapies 53 Raptiva R 53 Ceragenin ™ 53 commercialize dutogliptin 53 TRAIL receptor antibodies 53 commercialize MDV# 53 immunotherapeutic approaches 53 Adagen 53 dirucotide MBP# 53 BiolineRX 53 CEFF financings subject 53 hepatitis B immune globulin 53 hereditary emphysema 53 CTAP# Capsules 53 fluorinated carbohydrate mimics 53 Agenerase 53 Lispro 53 CancerVax Corporation 53 reslizumab 53 Cellegesic 53 Locteron exclusively 53 Nimotuzumab 53 Troxatyl 53 Medgenics 53 psoriasis rheumatoid arthritis 53 Adenuric R 53 Muraglitazar 53 novel immunotherapies 53 IMC #F# 53 TransMID TM 53 liposomal formulation 53 proprietary MSCRAMM ® 53 BioLineRx 53 SYCREST 53 Captisol ® 53 Vitamin D analogue 53 Cerashield TM 53 SNT MC# 53 Crop BioScience 53 LRAT 53 NASDAQ CGEN 53 Zor Pharmaceuticals 53 PEGylated Fab fragment 53 Aganocide TM 53 Fibrillex TM 53 Aflibercept 53 Cancidas 53 Cerezyme imiglucerase 53 Biovitrum AB 53 Ucyclyd Pharma Inc. 53 PER.C6 53 Luteinizing Hormone Releasing Hormone 53 Emezine 53 Receives Approvable Letter 53 DiaPep# 53 Microbix Biosystems 53 BioSante licensees 53 PROVIGIL ® 53 Nabi HB R 53 Paris IPN Euronext 53 Initiates Phase III 53 anionic backbone 53 StemEx 53 Tibotec BVBA 53 Orapred ODT 53 Elan Pharma 53 Cabilly patent 53 tafluprost 53 OGeS 53 Synerx Pharma 53 bardoxolone 53 LSE PFZ 53 D Pharm 53 ASONEP ™ 53 Rasagiline 53 anticancer therapeutics 53 prostone 53 PrevOnco 53 RedHill Biopharma Ltd. 53 collagenase clostridium histolyticum 53 BioNumerik 53 Omrix Biopharmaceuticals 53 inherited retinal 53 Generx TM 53 RECOTHROM ® 53 Novartis NVS Snapshot Report 53 Pathway Inhibitor 53 Junovan TM 53 UltiMAb 53 Bertek Pharmaceuticals 53 BioOne Corporation 53 oral prodrug 53 Kyowa Hakko Kogyo Co. 53 apaziquone 53 ProBioGen 53 enzyme glucocerebrosidase 53 Virulizin 53 Nuron Biotech 53 BioCancell 53 Multipotent 53 Affibody ® molecules 53 Canadian drugmaker Aeterna 53 TÎ ² 4 53 antisense inhibitors 53 glial derived neurotrophic 53 commercializes oncology 53 PentaStaph 53 markets HP Acthar 53 AMEX RGN 53 SGLT Inhibitors 53 ciprofloxacin hydrochloride 53 ATryn R 53 GLASSIA ™ 53 including eniluracil ADH 53 Proleukin 53 coagulation disorders 53 phage display technology 53 pancreatic endocrine 53 EHT AGN 53 IAP inhibitors 53 hyaluronidase rHuPH# 53 homozygous FH 53 Myozyme Lumizyme 53 Theramex 53 Zirgan 53 RNA antagonists 53 XIAPEX ® 53 GRNVAC1 53 Shigamabs ® 53 Vegenics 53 Onconase 53 Announces Tentative Approval 53 A1PI 53 Dacetuzumab 53 gamma globin gene 53 unresectable recurrent 53 PEGylated anti 53 Nasdaq HALO biopharmaceutical 53 Anti CD# Antibody 53 PerClot 53 SynCon 53 Anidulafungin 53 Surfaxin LS 53 PolyHeme ® 53 secondary amenorrhea 53 Evithrom 53 Antibody Discovery 53 ZFNs clinical trials 53 TASE BOSC 53 candidate epratuzumab 53 Gonal f R follitropin 53 Piramed 53 Submits NDA 53 tiapamil 53 Friedreich Ataxia FRDA 53 EC Cysteamine 53 KellBenx 52 Glufosfamide 52 Cell Kinetics 52 Afluria 52 Kufs disease 52 Receives Positive Opinion 52 CytoGam 52 glucokinase activator 52 Thrombin 52 ABILIFY ® 52 JAK2 Inhibitor 52 toremifene citrate 52 Fragile X mental retardation 52 Insegia 52 EXACT maintains 52 PF # [002] 52 Syntonix Pharmaceuticals 52 Survivin antagonist 52 Kosan motilin agonist 52 Wellstat Therapeutics 52 Merz Pharmaceuticals GmbH 52 SOLTAMOX TM tamoxifen citrate 52 Juvantia 52 mitoxantrone concentrate 52 Rosetta Genomics Ltd. 52 Merck Sante sas 52 GeneraMedix Inc. 52 glucokinase activators 52 biosurgical 52 Antisense Pharma GmbH 52 Presents Preclinical Data 52 fipamezole 52 teplizumab 52 NTDDS 52 Protalix BioTherapeutics PLX 52 antisense drug 52 immunologically compatible 52 NYSE Amex NBS 52 Loramyc R 52 voclosporin 52 JV SpeBio 52 mGluR5 PAM 52 cloned primate 52 lumiliximab 52 orally administered synthetic retinoid 52 Tetrabenazine 52 rhMBL 52 Vantas 52 Marketing Authorisation 52 submitted Biologics License 52 theranostic 52 Xyntha 52 Intravenous Human 52 Firdapse 52 Severe VOD 52 synthetic retinoid 52 Azmacort R 52 RenaZorb 52 Sebivo 52 Cetrotide R 52 immune modulatory 52 SOD1 gene 52 Through Glycoscience R 52 hormone LHRH antagonist 52 ISENTRESS raltegravir 52 Irinotecan Hydrochloride Injection 52 Hadasit 52 histone deacetylase HDAC inhibitors 52 Firazyr ® 52 Somatuline R Autogel R 52 SOLVAY PHARMACEUTICALS 52 Pharmion GmbH wholly owned 52 Mipomersen 52 TELINTRA 52 Advancing Drugs 52 NYSE Amex BTX 52 Ixabepilone 52 Alfa Wassermann 52 MediGene focuses 52 Immunotherapeutic 52 topical anti infective 52 Rapinyl 52 Prism Pharmaceuticals 52 Plasmid DNA 52 ViaCyte 52 OLEPTRO 52 Jewish parliamentarian Siamak 52 L BLP# 52 commercialize ISA# 52 encapsulated porcine insulin 52 Sanochemia 52 Davanat 52 dermatological indications 52 Humanitarian Device Exemption 52 Proquin XR 52 Mitsubishi Tanabe Pharma 52 IMiDs ® compound 52 transgenically produced product 52 gastro intestinal inflammation 52 Panzem R NCD 52 Thyrogen 52 Nexavar sorafenib 52 Myolimus 52 Soliris TM eculizumab 52 StemEx R 52 Apokyn ® 52 Taisho Pharmaceuticals 52 muscular dystrophy cystic fibrosis 52 Vidaza azacitidine 52 oral antiplatelet agent 52 name Cetrotide R 52 Embryonic stem cells ESCs 52 Stemedica 52 NYSE Amex PTN 52 Vernalis plc 52 FDA Accepts 52 GeneICE 52 Bioceros 52 Nasdaq PARD 52 allogeneic bone marrow 52 adult mesenchymal stem 52 Roche OTC RHHBY 52 NASDAQ BTRX pharmaceutical 52 Indaflex 52 Teikoku Seiyaku Co. 52 totipotent 52 insulin secreting beta 52 GlaxoSmithKline Biologicals GSK 52 hypervascular tumors 52 Dorad 52 Helsinn Healthcare 52 Progenitor Cell 52 Neurimmune 52 Kyowa Hakko Kirin 52 Protalix BioTherapeutics Inc. 52 Cinryze ™ 52 TEVA Quote Chart 52 monoclonal antibody therapeutics 52 pluripotent human 52 acadesine 52 PGL# 52 Induced pluripotent stem cells 52 NovaBay Aganocide compounds 52 Cellcom Israel Ltd. 52 epoetin delta 52 Monoclonal antibody 52 IG HCR ;) CO 52 Ampligen r 52 AERx iDMS 52 Letairis ambrisentan 52 Quark Pharmaceuticals 52 CYCLOSET ® 52 gastrointestinal mucositis 52 OctoPlus licensed 52 Levulan ® PDT 52 COMBIDEX R ferumoxtran 52 HYVISC R 52 Inc. QWIPTECH holds 52 commercialize conjugates consisting 52 Virium 52 CERVARIX R 52 Inc. Tianlong 52 Trovax 52 Nasdaq HALO 52 SuperAntibody 52 LEVADEX ™ 52 Corp. Nasdaq GENZ 52 lipid nanoparticle 52 Maribavir 52 Ceflatonin 52 Anti VEGF 52 investigational oral anticoagulant 52 incorporate CXA 52 pafuramidine maleate 52 Neurim Pharmaceuticals 52 International SRL BLS 52 tetracycline antibiotic 52 Cloning embryos 52 CytoFab 52 Unit Dose Budesonide 52 treats Gaucher disease 52 Ipsen SA 52 Can Fite BioPharma 52 Holding AG ROG.VX 52 regenerative medicine therapies 52 Application BLA 52 Nexavar sorafenib tablets 52 Defiante 52 Receives Tentative Approval 52 cyclin dependent kinase inhibitor 52 Glufast 52 Glucagon Like Peptide 52 romazarit 52 pancreatic enzyme replacement 52 Announces License Agreement 52 Biopharma OTCBB VODG 52 Manja Bouman CEO 52 RedHill Biopharma 52 TRANSDUR ™ 52 Taclonex R 52 BioControl 52 Currently RegeneRx 52 By JAMAAL ABDUL 52 Zenpep 52 SEBIVO 52 metastatic neuroendocrine tumors 51 Valganciclovir 51 NSE SUNPHARMA 51 Transfluor 51 Sigma Tau Pharmaceuticals 51 DEB# 51 AdVac 51 KSP inhibitor 51 adenosine A2A 51 Metabasis Therapeutics 51 Ceragenix 51 Pierre Fabre Medicament 51 AnGes 51 GW# [003] 51 inflammatory autoimmune 51 Sanquin 51 ARRY # 51 Genotyping Test 51 Receives Complete Response 51 anti CD3 antibody 51 DIABECELL 51 ASONEP 51 GP Pharm 51 Submits Supplemental 51 Receives CE Marking 51 BCR ABL inhibitors 51 miconazole Lauriad R 51 Privigen 51 SpeBio joint venture 51 Presents Preclinical 51 osteolytic bone disease 51 Orencia abatacept 51 Cytokine PharmaSciences 51 NASDAQ CRXL 51 Azur Pharma 51 Commercialization Agreement 51 TransPharma Medical Ltd. 51 vaccine GRNVAC1 51 dihydrofolate reductase 51 Mg Usa 51 Cutanea 51 pleconaril 51 Kosan epothilone program 51 ThyroTec LLC 51 Duchenne muscular dystrophy DMD 51 OMJPI 51 Phusion Laboratories 51 TKPHF 51 Angiox ® 51 CCR5 receptor antagonist 51 HYC# 51 Receives Tentative FDA 51 Nasdaq GIVN 51 inhibitor PPI 51 dihydrochloride Tablets 51 Velcade bortezomib 51 Marqibo TM 51 Sanvar R 51 Janssen Pharmaceutica NV 51 Kissei Pharmaceuticals 51 Preotact R 51 Ophthotech 51 recombinant insulin 51 Selective Electrochemical Tumor Ablation 51 hESC derived 51 XIAPEX 51 Alemtuzumab 51 Merck OSI Pharmaceuticals 51 Serostim R 51 Orphan Therapeutics 51 Etubics 51 NasdaqGM SPPI 51 EGRIFTA ™ 51 Raptiva ® 51 thalidomide Thalomid 51 monoclonal antibody conjugated 51 Abbokinase 51 Ilaris ® 51 Actimmune R 51 Idera Pharmaceuticals 51 NanoTab 51 JAK3 51 Ercole Biotech 51 Oncoscience AG 51 Leydig cells 51 Multiferon R 51 undergoing hematopoietic stem 51 BUSINESS WIRE Elron Electronic 51 Olerup SSP 51 Alfa Wassermann SpA 51 ONCASPAR 51 CureTech 51 Transdermal Patch 51 Ceflatonin R 51 Atripla combines 51 Avian Transgenic Technology 51 Imatinib Mesylate 51 Gets FDA Clearance 51 Myrexis Inc. 51 Aganocide ® 51 Endotis 51 mutated K ras 51 Hadasit Bio Holdings 51 recombinant interferon 51 Zeneus 51 tetrabenazine 51 Enbrel rheumatoid arthritis 51 Mg Uk 51 Fast Track Designation 51 riboflavin vitamin B2 51 Sanwa Kagaku Kenkyusho Co. 51 Zenyaku Kogyo Co. 51 targeted antifolate 51 Kuvan TM sapropterin 51 Nexavar tablets 51 Apokyn 51 Inc. Nasdaq SGXP 51 HQK 51 topical ophthalmic 51 Obtains License 51 Exclusive License 51 commercialize ecallantide 51 antiviral cytokines 51 Gadot Biochemical Industries 51 lymphoid organs 51 ZEFTERA TM Zevtera TM 51 Certican 51 Through Glycoscience ® 51 demethylating agent 51 CEQ# 51 Evoltra TM 51 Axiogenesis 51 generation purine nucleoside 51 eligen 51 tramiprosate ALZHEMED TM 51 OXIGON TM 51 Zentaris 51 radiotherapeutic 51 Keryx Biopharmaceuticals 51 ReFacto 51 sells Osteocel R 51 manufacturing interventional vascular 51 cIAI 51 ularitide 51 cinacalcet HCl 51 OMRIX Biopharmaceuticals 51 fluoro sorafenib 51 pentostatin 51 Mimpara R 51 BioSyent Pharma 51 BioGeneriX 51 Posiphen TM 51 NeutroSpec TM 51 ASX BLT 51 Hepatocytes 51 NasVax 51 immunological diseases 51 TolerRx 51 Luveris 51 Thelin tm 51 Amigal 51 selective modulator 51 Kissei Pharmaceutical 51 Nasdaq AEGR 51 VaxImmune 51 GLASSIA 51 Romiplostim 51 Proellex TM 51 investigational integrase inhibitor 51 Igeneon 51 Taro Pharmaceuticals 51 Osteoclasts 51 ABLYNX 51 haematological cancers 51 miRNA therapeutics 51 taliglucerase 51 BioWa 51 OTCBB APCSF 51 Omacetaxine 51 Lupuzor 51 Seikagaku Corporation 51 Stimuvax R 51 Licenses Novel 51 Chroma Therapeutics 51 AclarusDx ™ 51 TTR gene 51 Cetrotide 51 Dalbavancin 51 InterfeRx TM 51 DGAT1 51 histone deacetylase inhibitor 51 Saizen ® 51 Eraxis 51 VALSTAR 51 TSX SHQ 51 GRNCM1 51 Octreotide 51 Transfection Reagent 51 novel immunomodulatory 51 FUS1 51 rheumatoid arthritis psoriasis Crohn